How Sponsors Can Make It Easier For Rare Disease Patients And Families To Participate In Trials
Source: Parexel International
By Rachel Smith, Global Head of the Rare Disease Center of Excellence, Parexel
A recent study was conducted to gain insights into the experiences of patients and their caregivers living with rare neurological disorders. Rachel Smith, the Global Head of the Rare Disease Center of Excellence, shares key findings from this research, offering valuable strategies for sponsors to improve patient recruitment and retention in clinical trials targeting neurological conditions.
For those interested in the research methodology, we provide a detailed description at the conclusion of this Q&A.
access the Q&A!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Parexel International
This website uses cookies to ensure you get the best experience on our website. Learn more